Literature DB >> 15358649

Prospective study of serological conversion as a risk factor for development of leprosy among household contacts.

J T Douglas1, R V Cellona, T T Fajardo, R M Abalos, M V F Balagon, P R Klatser.   

Abstract

Although the prevalence of leprosy has declined over the years, there is no evidence that incidence rates are falling. A method of early detection of those people prone to develop the most infectious form of leprosy would contribute to breaking the chain of transmission. Prophylactic treatment of serologically identified high-risk contacts of incident patients should be an operationally feasible approach for routine control programs. In addition, classification of high-risk household contacts will allow control program resources to be more focused. In this prospective study, we examined the ability of serology used for the detection of antibodies to phenolic glycolipid I of Mycobacterium leprae to identify those household contacts of multibacillary leprosy patients who had the highest risk of developing leprosy. After the start of multidrug therapy for the index case, a new case of leprosy developed in one in seven of the 178 households studied. In households where new cases appeared, the seropositivity rates were significantly higher (P < 0.001) than those in households without new cases. Seropositive household contacts had a significantly higher risk of developing leprosy (relative hazard adjusted for age and sex [aRH], 7.2), notably multibacillary leprosy (aRH = 24), than seronegative contacts.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15358649      PMCID: PMC515277          DOI: 10.1128/CDLI.11.5.897-900.2004

Source DB:  PubMed          Journal:  Clin Diagn Lab Immunol        ISSN: 1071-412X


  15 in total

Review 1.  Mycobacterium leprae--millennium resistant! Leprosy control on the threshold of a new era.

Authors:  J Visschedijk; J van de Broek; H Eggens; P Lever; S van Beers; P Klatser
Journal:  Trop Med Int Health       Date:  2000-06       Impact factor: 2.622

Review 2.  Serology: recent developments, strengths, limitations and prospects: a state of the art overview.

Authors:  Linda Oskam; Erik Slim; Samira Bührer-Sékula
Journal:  Lepr Rev       Date:  2003-09       Impact factor: 0.537

3.  The eradication of smallpox: organizational learning and innovation in international health administration.

Authors:  J W Hopkins
Journal:  J Dev Areas       Date:  1988-04

4.  The nasal dicharge in leprosy: clinical and bacteriological aspects.

Authors:  T F Davey; R J Rees
Journal:  Lepr Rev       Date:  1974-06       Impact factor: 0.537

5.  Serological reactivity and early detection of leprosy among contacts of lepromatous patients in Cebu, the Philippines.

Authors:  J T Douglas; R V Celona; R M Abalos; M G Madarang; T Fajardo
Journal:  Int J Lepr Other Mycobact Dis       Date:  1987-12

Review 6.  The epidemiology of Mycobacterium leprae: recent insight.

Authors:  S M van Beers; M Y de Wit; P R Klatser
Journal:  FEMS Microbiol Lett       Date:  1996-03-01       Impact factor: 2.742

7.  Dipstick assay to identify leprosy patients who have an increased risk of relapse.

Authors:  S Bührer-Sékula; M G Cunha; N T Foss; L Oskam; W R Faber; P R Klatser
Journal:  Trop Med Int Health       Date:  2001-04       Impact factor: 2.622

8.  Simple and fast lateral flow test for classification of leprosy patients and identification of contacts with high risk of developing leprosy.

Authors:  S Bührer-Sékula; H L Smits; G C Gussenhoven; J van Leeuwen; S Amador; T Fujiwara; P R Klatser; L Oskam
Journal:  J Clin Microbiol       Date:  2003-05       Impact factor: 5.948

9.  Evaluation of Mycobacterium leprae antigens in the monitoring of a dapsone-based chemotherapy of previously untreated lepromatous patients in Cebu, Philippines.

Authors:  P R Klatser; M Y de Wit; T T Fajardo; R V Cellona; R M Abalos; E C de la Cruz; M G Madarang; D S Hirsch; J T Douglas
Journal:  Lepr Rev       Date:  1989-09       Impact factor: 0.537

10.  Evaluation of Mycobacterium leprae antigens in the serological monitoring of a clofazimine-based chemotherapeutic study of dapsone resistant lepromatous leprosy patients in Cebu, Philippines.

Authors:  J T Douglas; D S Hirsch; T T Fajardo; R V Cellona; R M Abalos; E C de la Cruz; M G Madarang; M Y de Wit; P R Klatser
Journal:  Lepr Rev       Date:  1989-03       Impact factor: 0.537

View more
  34 in total

1.  Serum anti-phenolic glycolipid-1 IgA correlates to IgM isotype in leprosy patients: a possible candidate for seroepidemiological surveys?

Authors:  Alexandre C de Macedo; Juliana A Guimarães; Raphael O Rodrigues; Thiago D V Araújo; Clodis M Tavares; Paula B Cabral; Maria Isabel de Moraes-Pinto; Aparecida T Nagao-Dias
Journal:  J Clin Lab Anal       Date:  2017-06-08       Impact factor: 2.352

2.  Synergistic antigen combinations for the development of interferon gamma release assays for paucibacillary leprosy.

Authors:  R M Oliveira; E M Hungria; A de Araújo Freitas; A L O M de Sousa; M B Costa; S G Reed; M S Duthie; M M A Stefani
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2014-03-12       Impact factor: 3.267

3.  Insight toward early diagnosis of leprosy through analysis of the developing antibody responses of Mycobacterium leprae-infected armadillos.

Authors:  Malcolm S Duthie; Richard W Truman; Wakako Goto; Joanne O'Donnell; Marah N Hay; John S Spencer; Darrick Carter; Steven G Reed
Journal:  Clin Vaccine Immunol       Date:  2010-12-22

4.  Use of protein microarrays to define the humoral immune response in leprosy patients and identification of disease-state-specific antigenic profiles.

Authors:  Nathan A Groathouse; Amol Amin; Maria Angela M Marques; John S Spencer; Robert Gelber; Dennis L Knudson; John T Belisle; Patrick J Brennan; Richard A Slayden
Journal:  Infect Immun       Date:  2006-09-11       Impact factor: 3.441

5.  From genome-based in silico predictions to ex vivo verification of leprosy diagnosis.

Authors:  Annemieke Geluk; John S Spencer; Kidist Bobosha; Maria C V Pessolani; Geraldo M B Pereira; Sayera Banu; Nadine Honoré; Stephen T Reece; Murdo MacDonald; Bishwa Raj Sapkota; Chaman Ranjit; Kees L M C Franken; Martha Zewdie; Abraham Aseffa; Rabia Hussain; Mariane M Stefani; Sang-Nae Cho; Linda Oskam; Patrick J Brennan; Hazel M Dockrell
Journal:  Clin Vaccine Immunol       Date:  2009-01-28

6.  Use of protein antigens for early serological diagnosis of leprosy.

Authors:  Malcolm S Duthie; Wakako Goto; Greg C Ireton; Stephen T Reece; Ludimila P V Cardoso; Celina M T Martelli; Mariane M A Stefani; Maria Nakatani; Robson Crusue de Jesus; Eduardo M Netto; Ma V F Balagon; Esterlina Tan; Robert H Gelber; Yumi Maeda; Masahiko Makino; Dan Hoft; Steven G Reed
Journal:  Clin Vaccine Immunol       Date:  2007-09-26

7.  Serology with ML Flow test in health professionals from three different states of Brazil.

Authors:  Karla Lucena Sampaio Calado; Mônica Maria Ferreira Magnanini; Rodrigo Scaliante de Moura; Maria Eugenia Noviski Gallo; Samira Bührer-Sékula; Maria Leide Wand-Del-Rey de Oliveira
Journal:  An Bras Dermatol       Date:  2013 Nov-Dec       Impact factor: 1.896

8.  ML0405 and ML2331 are antigens of Mycobacterium leprae with potential for diagnosis of leprosy.

Authors:  Stephen T Reece; Greg Ireton; Raodoh Mohamath; Jeffrey Guderian; Wakako Goto; Robert Gelber; Nathan Groathouse; John Spencer; Patrick Brennan; Steven G Reed
Journal:  Clin Vaccine Immunol       Date:  2006-03

9.  CHEMOPROPHYLAXIS TO CONTROL LEPROSY AND THE PERSPECTIVE OF ITS IMPLEMENTATION IN BRAZIL: A PRIMER FOR NON-EPIDEMIOLOGISTS.

Authors:  Sergio Souza da Cunha; Ana Luiza Bierrenbach; Vitor Hugo Lima Barreto
Journal:  Rev Inst Med Trop Sao Paulo       Date:  2015-12       Impact factor: 1.846

10.  Early Revelation of Leprosy in China by Sequential Antibody Analyses with LID-1 and PGL-I.

Authors:  Pan Qiong-Hua; Zheng Zhong-Yi; Yang Jun; Wen Yan; Yuan Lian-Chao; Li Huan-Ying; Steven G Reed; Malcolm S Duthie
Journal:  J Trop Med       Date:  2013-01-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.